Oral Stent Device for Radiation Treatments of Oral Cancers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04041141|
Recruitment Status : Not yet recruiting
First Posted : August 1, 2019
Last Update Posted : August 1, 2019
The purpose of this study is to examine that ability of the experimental oral stent device to reduce the volume of mandible receiving >55 Gy by 50%during radiation treatment as assessed duri radiation treatment planning. Patients will have CT scans at three time-points during their standard of care radiation treatment. During these visits patients will receive scans via CT or cone beam CT scan, with both the standard and experimental oral stent devices.
During radiation treatment patients will receive the standard oral stent device.
|Condition or disease||Intervention/treatment|
|Tongue Tumor Tongue Cancer||Diagnostic Test: CT Scan Device: Experimental Oral Stent Device|
|Study Type :||Observational|
|Estimated Enrollment :||10 participants|
|Official Title:||A Pilot Study Assessing an Oral Stent Device for Radiation Treatments of Oral Cancers|
|Estimated Study Start Date :||August 2019|
|Estimated Primary Completion Date :||December 31, 2019|
|Estimated Study Completion Date :||December 31, 2021|
Patients receiving curative radiation treatment for an oral cancer.
Diagnostic Test: CT Scan
An additional cone beam CT will be repeated at midcourse of therapy (3rd week) and during the end of therapy (5th week)
Device: Experimental Oral Stent Device
Patients undergoing standard of care planning for head and neck tongue cancer will have a radiation plan of the body imaged via CT scan construction with the experimental oral stent device in place
- The volume of mandible irradiated to >55 Gy [ Time Frame: volume irradiated at Day 0 ]
- The position of the fiducial marker [ Time Frame: Change in position at Day 0, Week 3, Week 5 ]Fiducial coordinate measured (mm) on XYZ on planning CT
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04041141
|Contact: Mark Langer, MDemail@example.com|
|Contact: Amy Millerfirstname.lastname@example.org|
|United States, Indiana|
|Indiana University Melvin & Bren Simon Cancer Center||Not yet recruiting|
|Indianapolis, Indiana, United States, 46202|
|Contact: Amy Miller 317-278-7614 email@example.com|
|Principal Investigator: Mark Langer, MD|
|Principal Investigator:||Mark Langer, MD||Indiana University|